Learn More
BACKGROUND Loteprednol etabonate is a site-active corticosteroid with efficacy and safety in treating ocular inflammation at the 0.5% concentration. Evidence from dose-response studies suggested that the 0.2% concentration might be effective in treating ocular allergy. OBJECTIVES The objective of this study was to evaluate the effects of 0.2% loteprednol(More)
PURPOSE To evaluate the efficacy and safety of loteprednol etabonate 0.5% as prophylactic treatment for the ocular signs and symptoms of seasonal allergic conjunctivitis. METHODS In this randomized, double-masked, placebo-controlled, parallel study, 293 adults with history of seasonal allergic conjunctivitis were treated with either loteprednol etabonate(More)
This paper reports findings from the initial stage of a funded collaborative research program aimed at identification of E-Commerce cultural change and technology uptake experience in Australia and comparison of Australian and United States experience. In collaboration with Georgia State University and employing the study script and methodology used in(More)
This paper presents a two level factor model describing gender differences in perceptions of the relative contribution and importance of education and skills required of new information systems (IS) professionals. Model development took account of technical skills found in most IS programs, other business oriented academic studies, and soft skills sought by(More)